433 related articles for article (PubMed ID: 21641353)
41. Intermediate-signal-intensity late gadolinium enhancement predicts ventricular tachyarrhythmias in patients with hypertrophic cardiomyopathy.
Appelbaum E; Maron BJ; Adabag S; Hauser TH; Lesser JR; Haas TS; Riley AB; Harrigan CJ; Delling FN; Udelson JE; Gibson CM; Manning WJ; Maron MS
Circ Cardiovasc Imaging; 2012 Jan; 5(1):78-85. PubMed ID: 22135401
[TBL] [Abstract][Full Text] [Related]
42. Reproducibility of Gadolinium Enhancement Patterns and Wall Thickness in Hypertrophic Cardiomyopathy.
Rodriguez-Granillo GA; Deviggiano A; Capunay C; Zan MC; Carrascosa P
Arq Bras Cardiol; 2016 Jul; 107(1):48-54. PubMed ID: 27305110
[TBL] [Abstract][Full Text] [Related]
43. Endogenous contrast T1rho cardiac magnetic resonance for myocardial fibrosis in hypertrophic cardiomyopathy patients.
Wang C; Zheng J; Sun J; Wang Y; Xia R; Yin Q; Chen W; Xu Z; Liao J; Zhang B; Gao F
J Cardiol; 2015 Dec; 66(6):520-6. PubMed ID: 25981868
[TBL] [Abstract][Full Text] [Related]
44. Mitral annular plane systolic excursion is an easy tool for fibrosis detection by late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
Doesch C; Sperb A; Sudarski S; Lossnitzer D; Rudic B; Tülümen E; Heggemann F; Schimpf R; Schoenberg SO; Borggrefe M; Papavassiliu T
Arch Cardiovasc Dis; 2015; 108(6-7):356-66. PubMed ID: 25863428
[TBL] [Abstract][Full Text] [Related]
45. Myocardial Fibrosis in Hypertrophic Cardiomyopathy: Volumetric Assessment of Late Enhancement Provided by Cardiac Computed Tomography.
Langer C; Schaefer P; Lutz M; Eden M; Hohnhorst M; Harders H; Faber L; Jansen O; Both M; Frey N
J Comput Assist Tomogr; 2015; 39(5):797-803. PubMed ID: 26125299
[TBL] [Abstract][Full Text] [Related]
46. Clinical significance of late gadolinium enhancement in patients<20 years of age with hypertrophic cardiomyopathy.
Smith BM; Dorfman AL; Yu S; Russell MW; Agarwal PP; Mahani MG; Lu JC
Am J Cardiol; 2014 Apr; 113(7):1234-9. PubMed ID: 24513464
[TBL] [Abstract][Full Text] [Related]
47. Redefinition of uremic cardiomyopathy by contrast-enhanced cardiac magnetic resonance imaging.
Mark PB; Johnston N; Groenning BA; Foster JE; Blyth KG; Martin TN; Steedman T; Dargie HJ; Jardine AG
Kidney Int; 2006 May; 69(10):1839-45. PubMed ID: 16508657
[TBL] [Abstract][Full Text] [Related]
48. T1 Mapping in Discrimination of Hypertrophic Phenotypes: Hypertensive Heart Disease and Hypertrophic Cardiomyopathy: Findings From the International T1 Multicenter Cardiovascular Magnetic Resonance Study.
Hinojar R; Varma N; Child N; Goodman B; Jabbour A; Yu CY; Gebker R; Doltra A; Kelle S; Khan S; Rogers T; Arroyo Ucar E; Cummins C; Carr-White G; Nagel E; Puntmann VO
Circ Cardiovasc Imaging; 2015 Dec; 8(12):. PubMed ID: 26659373
[TBL] [Abstract][Full Text] [Related]
49. Assessment of myocardial deformation with cardiac magnetic resonance strain imaging improves risk stratification in patients with dilated cardiomyopathy.
Buss SJ; Breuninger K; Lehrke S; Voss A; Galuschky C; Lossnitzer D; Andre F; Ehlermann P; Franke J; Taeger T; Frankenstein L; Steen H; Meder B; Giannitsis E; Katus HA; Korosoglou G
Eur Heart J Cardiovasc Imaging; 2015 Mar; 16(3):307-15. PubMed ID: 25246506
[TBL] [Abstract][Full Text] [Related]
50. Prevalence and Progression of Late Gadolinium Enhancement in Children and Adolescents With Hypertrophic Cardiomyopathy.
Axelsson Raja A; Farhad H; Valente AM; Couce JP; Jefferies JL; Bundgaard H; Zahka K; Lever H; Murphy AM; Ashley E; Day SM; Sherrid MV; Shi L; Bluemke DA; Canter CE; Colan SD; Ho CY
Circulation; 2018 Aug; 138(8):782-792. PubMed ID: 29622585
[TBL] [Abstract][Full Text] [Related]
51. Distribution of late gadolinium enhancement in end-stage hypertrophic cardiomyopathy and dilated cardiomyopathy: differential diagnosis and prediction of cardiac outcome.
Machii M; Satoh H; Shiraki K; Saotome M; Urushida T; Katoh H; Takehara Y; Sakahara H; Ohtani H; Wakabayashi Y; Ukigai H; Tawarahara K; Hayashi H
Magn Reson Imaging; 2014 Feb; 32(2):118-24. PubMed ID: 24315973
[TBL] [Abstract][Full Text] [Related]
52. Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study.
Masci PG; Schuurman R; Andrea B; Ripoli A; Coceani M; Chiappino S; Todiere G; Srebot V; Passino C; Aquaro GD; Emdin M; Lombardi M
Circ Cardiovasc Imaging; 2013 Sep; 6(5):790-9. PubMed ID: 23934992
[TBL] [Abstract][Full Text] [Related]
53. [The association between cardiac mr feature tracking strain and myocardial late gadolinium enhancement in patients with hypertrophic cardiomyopathy].
Ozden O; Unlu S; Kilic DI; Sherif SA; Opan S; Kemal HS; Ozmen E; Tuner H; Bingol G; Barutcu A; Nasifov M; Bakan S; Goktekin O
Kardiologiia; 2023 Feb; 63(2):52-58. PubMed ID: 36880144
[TBL] [Abstract][Full Text] [Related]
54. Late gadolinium enhancement on cardiac magnetic resonance represents the depolarizing and repolarizing electrically damaged foci causing malignant ventricular arrhythmia in hypertrophic cardiomyopathy.
Sakamoto N; Kawamura Y; Sato N; Nimura A; Matsuki M; Yamauchi A; Kanno T; Tanabe Y; Takeuchi T; Natori S; Saijo Y; Aburano T; Hasebe N
Heart Rhythm; 2015 Jun; 12(6):1276-84. PubMed ID: 25684235
[TBL] [Abstract][Full Text] [Related]
55. Entropy of left ventricular late gadolinium enhancement and its prognostic value in hypertrophic cardiomyopathy a new CMR assessment method.
Zhao X; Jin F; Wang J; Zhao X; Wang L; Wei H
Int J Cardiol; 2023 Feb; 373():134-141. PubMed ID: 36395920
[TBL] [Abstract][Full Text] [Related]
56. CMR findings in patients with hypertrophic cardiomyopathy and atrial fibrillation.
Papavassiliu T; Germans T; Flüchter S; Doesch C; Suriyakamar A; Haghi D; Süselbeck T; Wolpert C; Dinter D; Schoenberg SO; van Rossum AC; Borggrefe M
J Cardiovasc Magn Reson; 2009 Sep; 11(1):34. PubMed ID: 19740409
[TBL] [Abstract][Full Text] [Related]
57. Pattern of late gadolinium enhancement predicts arrhythmic events in patients with non-ischemic cardiomyopathy.
Shin DG; Lee HJ; Park J; Uhm JS; Pak HN; Lee MH; Kim YJ; Joung B
Int J Cardiol; 2016 Nov; 222():9-15. PubMed ID: 27458824
[TBL] [Abstract][Full Text] [Related]
58. Extent of late gadolinium enhancement detected by cardiovascular magnetic resonance correlates with the inducibility of ventricular tachyarrhythmia in hypertrophic cardiomyopathy.
Fluechter S; Kuschyk J; Wolpert C; Doesch C; Veltmann C; Haghi D; Schoenberg SO; Sueselbeck T; Germans T; Streitner F; Borggrefe M; Papavassiliu T
J Cardiovasc Magn Reson; 2010 May; 12(1):30. PubMed ID: 20492668
[TBL] [Abstract][Full Text] [Related]
59. Myocardial fibrosis severity on cardiac magnetic resonance imaging predicts sustained arrhythmic events in hypertrophic cardiomyopathy.
Prinz C; Schwarz M; Ilic I; Laser KT; Lehmann R; Prinz EM; Bitter T; Vogt J; van Buuren F; Bogunovic N; Horstkotte D; Faber L
Can J Cardiol; 2013 Mar; 29(3):358-63. PubMed ID: 22749647
[TBL] [Abstract][Full Text] [Related]
60. Significance of Late Gadolinium Enhancement at Right Ventricular Attachment to Ventricular Septum in Patients With Hypertrophic Cardiomyopathy.
Chan RH; Maron BJ; Olivotto I; Assenza GE; Haas TS; Lesser JR; Gruner C; Crean AM; Rakowski H; Rowin E; Udelson J; Lombardi M; Tomberli B; Spirito P; Formisano F; Marra MP; Biagini E; Autore C; Manning WJ; Appelbaum E; Roberts WC; Basso C; Maron MS
Am J Cardiol; 2015 Aug; 116(3):436-41. PubMed ID: 26026863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
